Solubilization and functional reconstitution of human neuropeptide FF2 receptors

Analytical Biochemistry

Volumn 398, Issue 2, 2010, Pages 225-229

  Talmont, Frank ^a   Mollereau, Catherine ^a   Muller, Isabelle ^a   Zajac, Jean Marie ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Binding sites; Neuropeptide FF; Receptor; Reconstitution; Solubilization

Indexed keywords

BINDING SITES; LIPIDS; LIPOSOMES; PRECIPITATION (CHEMICAL);

BINDING ACTIVITIES; CHINESE HAMSTER OVARY CELLS; NEUROPEPTIDES; PRECIPITATION METHODS; RECEPTOR; RECONSTITUTION; SOLUBILIZATION; ZWITTERIONIC DETERGENTS;

SOLUBILITY;

3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; LIPID; LIPOSOME; MACROGOL; NEUROPEPTIDE FF2 RECEPTOR; NEUROPEPTIDE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING KINETICS; CELL MEMBRANE; CHO CELL; CONTROLLED STUDY; FEMALE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR SOLUBILIZATION;

CRICETULUS GRISEUS;

EID: 77649178900     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.12.012     Document Type: Article

References (24)

1. Roumy M., Zajac J.M. Neuropeptide FF, pain, and analgesia. Eur. J. Pharmacol. 1998, 345:1-11.
2. Panula P., Kalso E., Nieminen M., Kontinen V.K., Brandt A., Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res. 1999, 848:191-196.
3. Mollereau C., Roumy M., Zajac J.M. Opioid-modulating peptides: mechanisms of action. Curr. Top. Med. Chem. 2005, 5:341-355.
4. Zajac J.M. Neuropeptide FF: new molecular insights. Trends Pharmacol. Sci. 2001, 22:63.
5. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., Fujii R., Watanabe T., Kikuchi K., Terao Y., Yano T., Yamamoto T., Kawamata Y., Habata Y., Asada M., Kitada C., Kurokawa T., Onda H., Nishimura O., Tanaka M., Ibata Y., Fujino M. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat. Cell Biol. 2000, 2:703-708.
6. Kotani M., Mollereau C., Detheux M., Le Poul E., Brezillon S., Vakili J., Mazarguil H., Vassart G., Zajac J.M., Parmentier M. Functional characterization of a human receptor for neuropeptide FF and related peptides. Br. J. Pharmacol. 2001, 133:138-144.
7. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., Evans N.A., Schmidt D.B., Buckley P.T., Dytko G.M., Murdock P.R., Tan K.B., Shabon U., Nuthulaganti P., Wang D.Y., Wilson S., Bergsma D.J., Sarau H.M. Receptor for the pain modulatory neuropeptides NPFF and NPAF is an orphan G-protein-coupled receptor. J. Biol. Chem. 2000, 275:25965-25971.
8. 2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol. Pharmacol. 2005, 67:965-975.
9. Gherardi N., Zajac J.M. Neuropeptide FF receptors of mouse olfactory bulb: binding properties and stimulation of adenylate cyclase activity. Peptides 1997, 18:577-583.
10. Roumy M., Zajac J.M. Neuropeptide FF receptors couple to a cholera toxin-sensitive G-protein in rat dorsal raphe neurones. Eur. J. Pharmacol. 2001, 417:45-49.
11. Roumy M., Lorenzo C., Mazères S., Bouchet S., Zajac J.-M., Mollereau C. Physical association between neuropeptide FF (NPFF) and μ-opioid (MOP) receptors as a molecular basis for anti-opioid activity. J. Biol. Chem. 2007, 282:8332-8342.
12. Gouarderes C., Tafani J.A., Zajac J.M. Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord. Peptides 1998, 19:727-730.
13. 125I]EYF as selective radioligands. Neuroscience 2002, 115:349-361.
14. 2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: a comparative autoradiographic study. Synapse 2004, 51:249-269.
15. Mazarguil H., Gouarderes C., Tafani J.A., Marcus D., Kotani M., Mollereau C., Roumy M., Zajac J.M. Structure-activity relationships of neuropeptide FF: role of C-terminal regions. Peptides 2001, 22:1471-1478.
16. 125I]EYF: a new high affinity radioligand to neuropeptide FF receptors. Peptides 2001, 22:623-629.
17. 2) receptors. Neurochem. Intl. 2009, 55:815-819.
18. 35S]GTPγS binding. Neuropharmacology 2007, 52:376-386.
19. 1 receptor antagonists. Eur. J. Pharmacol. 2002, 451:245-256.
20. Hjelmeland L.M. A nondenaturing zwitterionic detergent for membrane biochemistry: design and synthesis. Proc. Natl. Acad. Sci. USA 1980, 77:6368-6370.
21. Chattopadhyay A., Harikumar K.G. Dependence of critical micelle concentration of a zwitterionic detergent on ionic strength: implications in receptor solubilization. FEBS Lett. 1996, 391:199-202.
22. Ofri D., Ritter A.M., Liu Y.F., Gioannini T.L., Hiller J.M., Simon E.J. Characterization of solubilized opioid receptors: reconstitution and uncoupling of guanine nucleotide-sensitive agonist binding. J. Neurochem. 1992, 58:628-635.
23. Pellegrino de Iraldi A., Santiago Aguilar J., Ochoa E.L. Ultrastructure of reconstituted membranes containing the muscarinic receptor. Neurochem. Res. 1986, 11:983-996.
24. Kinuta M., Takei K. Utilization of liposomes in vesicular transport studies. Cell Struct. Funct. 2002, 27:63-69.